George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 81.50
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

24 Nov 2023 07:00

RNS Number : 5277U
British Smaller Companies VCT PLC
24 November 2023
 

British Smaller Companies VCT plc

Unaudited Interim Results and Interim Management Report

for the six months ended 30 September 2023

British Smaller Companies VCT plc (the "Company") today announces its unaudited interim results for the six months ended 30 September 2023.

 

HIGHLIGHTS

· Total Return increase of 0.7p to 259.3p per share

· Net Asset Value at 30 September 2023 of 82.4p per share (31 March 2023: 83.7p) following payment of 2.0p dividend in the period

· The Board has declared a second interim dividend of 2.0p per share in respect of the year ending 31 March 2024, which will bring total dividends paid in the current financial year to 4.0p per share, which equates to 4.8 per cent of the opening net asset value per share.

· Two new investments and two follow-on investments totalling £6.0 million were completed during the period. Subsequent to the period end, a further follow-on investment totalling £0.8 million has been completed.

· £44.3 million raised in fully subscribed November 2022 offer, with shares allotted at the beginning of the year. Combined applications exceeding £45 million received to date in relation to September 2023 offer. Shares relating to approximately £30 million of combined applications to be allotted between 29 and 31 January 2024 with second and final allotment in early April 2024.

Chairman's Statement

I am pleased to present the interim results of British Smaller Companies VCT plc (the "Company") for the six months to 30 September 2023. 

The performance in the period reflects the Company's positive progress despite ongoing macroeconomic challenges and geopolitical uncertainty, achieving a Total Return of 0.7 pence, an increase of 0.8 per cent over the opening NAV. In contrast the FTSE Small Cap fell by 0.4 per cent over the same period.

Underlying portfolio companies remain resilient, showing adaptability to market conditions and focusing on efficient use of capital. Revenues continue to grow, contributing to positive revaluations even with valuation multiples remaining subdued. 

Over the past six months, the Company has completed two new investments to the portfolio, Workbuzz and GEEIQ totalling £4.9 million, and made two follow-on investments, totalling £1.1 million. Following the period end, a further £0.8 million has also been invested, taking the total invested so far this year to £6.8 million, following the £28.4 million invested in the full year to 31 March 2023.

Realisations in the Period

Realisations of investments generated total proceeds of £1.8 million in the period.

The Company realised its investment in Ncam in April, generating initial proceeds of £1.4 million. There is the potential for additional receipts of up to £1.2 million depending on the achievement of certain milestones over the coming years, which would see the Company fully recover its investment; £0.3 million of deferred proceeds have been recognised at the period end.

Post-period end, in November 2023, the Company exited its investments in E2E, a consultancy in the satellite industry, for £2.0 million, representing a 2.5x return on the Company's cost; and MacroArt, a large scale branding and signage specialist, for £1.5 million, representing a 2.0x return on the Company's cost. This was a pleasing outcome for the Company following a challenging hold period and reflects the Company's ethos of working hard to generate positive returns from all of its investments.

Financial Results

The investment portfolio generated a return of £2.4 million in the period, driven by positive revaluations from a number of companies.

Given the current interest rate environment, the Company is managing its treasury position to generate a positive return for shareholders, balanced against the primary objective of capital preservation. The Company's treasury operations generated £1.3 million of income in the period.

The movement in net asset value ("NAV") per ordinary share and the dividends paid are set out in the table below. 

Pence per

ordinary share

£000

NAV at 31 March 2023

83.7p

157,032

Net gain arising from investment portfolio

1.0p

2,376

Net operating costs

(0.1p)

(197)

Comprehensive income in the period

0.9p

2,179

Issue/buy-back of new shares*

(0.2p)

44,169

Total Return in the period

0.7p

46,348

NAV before the payment of dividends

84.4p

 

203,380

Dividends paid

(2.0p)

(4,816)

NAV at 30 September 2023

82.4p

 

198,564

Cumulative dividends paid

176.9p

Total Return: At 30 September 2023

259.3p

At 31 March 2023

258.6p

* The allotment of shares from the 2022/23 fundraising reduces total return per ordinary share as the fundraising was priced at the 31 December 2022 NAV, being the latest published NAV at the allotment date shortly after 31 March 2023.

Dividends

An interim dividend of 2.0 pence per ordinary share in respect of the year ending 31 March 2024 was paid on 28 July 2023, bringing the cumulative dividends paid to date to 176.9 pence per ordinary share. 

The Board has announced a second interim dividend of 2.0 pence per ordinary share for the year ending 31 March 2024 which, when combined with the above dividend, will bring total dividends paid in the current financial year to 4.0 pence per ordinary share (2023: 8.5 pence per ordinary share). The dividend will be paid on 8 December 2023 to shareholders on the shareholder register on 10 November 2023. 

Shareholder Relations

The shareholder workshop held on 20 June 2023 was well attended. Attendees heard from Tom Dunlop, CEO of Summize, and Philip Hunt, Chair of Vuealta. 

The Company will be hosting an online webinar on 27 November 2023 to provide an update to shareholders; for further details please contact Tracey Nice at tracey.nice@yfmep.com.

Documents such as the annual report are now received electronically by 81 per cent of shareholders, rather than by post, which helps to meet the Board's impact objectives and reduces printing costs. The Board continues to encourage all shareholders to take up this option.

The Company's website is refreshed on a regular basis and provides a comprehensive level of information in what I hope is a user-friendly format.

Regulatory Developments

In the Autumn Statement on 22 November 2023, the Government announced it would extend the sunset clause currently in place for Venture Capital Trusts until April 2035, and that it would include legislation to achieve this in the next Finance Bill.

In the period there have been no regulatory changes that impact the Company; the Manager continues to monitor for any amendments.

Most new portfolio investments are now self-assured as VCT qualifying on a case-by-case basis and always with confirmation from professional advisers that they are Qualifying Investments. Advance assurance is sought where there is an element of uncertainty over the application of the rules.

Fundraising

On 4 April 2023 the Company allotted shares from its fully subscribed 2022/23 share offer. £44.3 million was raised by the Company, resulting in the allotment of 53,559,905 ordinary shares.

Having assessed its expected cash requirements, the Company announced a new share offer on 20 September 2023, alongside British Smaller Companies VCT2 plc, with the intention of raising up to £90 million (in aggregate), which includes an over-allotment facility of £25 million. Applications exceeding £45 million have been received as of the date of this report, of which £27 million relate to the Company. The first allotment of £30 million of gross proceeds will take place between 29 and 31 January 2024. The second and final allotment will take place in early April 2024.

Outlook

Over the past six months it has been pleasing to see portfolio companies continue to grow revenues, and to see positive exit outcomes despite challenging conditions. The Company has a promising pipeline of both new investment and exit opportunities, and will continue to look for opportunities to deploy capital into the existing portfolio to support continued growth.

I thank shareholders for their continued support.

Rupert Cook

Chairman

Objectives and Strategy

The Company's objective is to maximise Total Return and provide investors with a long-term tax free dividend yield whilst maintaining the Company's status as a venture capital trust.

Investment Strategy

The Company seeks to build a broad portfolio of investments in early-stage companies focused on growth, with the aim of spreading the maturity profiles and maximising return, as well as ensuring compliance with the VCT Regulations.

The Company predominantly invests in unquoted smaller companies and expects that this will continue to make up the significant majority of the portfolio. It will also retain holdings in cash or near-cash investments to provide a reserve of liquidity which will maximise the Company's flexibility as to the timing of investment acquisitions and disposals, dividend payments and share buy-backs.

Unquoted investments are structured using various investment instruments, including ordinary shares, preference shares, convertible securities and very occasionally loan stock, to achieve an appropriate balance of income and capital growth, having regard to the VCT Regulations. The portfolio is diversified by investing in a broad range of industry sectors. The normal investment period into the portfolio companies is expected to be typically between the range of five to seven years.

Investment Policy

The investment policy of the Company is to invest in UK businesses across a broad range of sectors that blends a mix of businesses operating in established and emerging industries that offer opportunities in the application and development of innovation in their products and services.

These investments will all meet the definition of a Qualifying Investment and be primarily in unquoted UK companies. It is anticipated that the majority of these will be re-investing their profits for growth and the investments will comprise mainly equity instruments.

The Company seeks to build a broad portfolio of investments in early-stage companies focused on growth with the aim of spreading the maturity profiles and maximising return as well as ensuring compliance with the VCT guidelines.

?Investment Review

The Company's portfolio at 30 September 2023 has a value of £130.3 million. The top ten investments represent 42.4 per cent of the net asset value with the largest representing 12.7 per cent of the net asset value.

The movements in the investment portfolio are set out below:

 

Portfolio

Listed investment funds

Investment portfolio

£million

£million

£million

Opening fair value at 1 April 2023

123.4

4.0

127.4

Additions

6.0

-

6.0

Disposal proceeds

(1.7)

(0.1)

(1.8)

Gain (loss) arising from the investment portfolio

2.6

(0.3)

2.3

Closing fair value at 30 September 2023

130.3

3.6

133.9

 

The Company's portfolio delivered a positive performance over the period, generating a return of £2.6 million.

There were upward revaluations from several portfolio companies including Unbiased, Traveltek, E2E, Displayplan and MacroArt, offset by decreases from Relative Insight, Wooshii and ACC.

Realisation of Investments

During the six months to 30 September 2023 the Company generated £1.8 million from disposals, in line with the opening carrying value and a loss of £0.9 million on cost. Further details are given in note 6.

Investments

During the six months ended 30 September 2023, the Company completed four investments, totalling £6.0 million. This comprised two new investments of £4.9 million and two follow-on investments totalling £1.1 million. The breakdown of these investments is shown below:

New

Follow-on

Total

Company

Description

£million

£million

£million

Workbuzz

SaaS-based employee engagement survey and insights platform

2.6

-

2.6

GEEIQ

Data and market intelligence platform in the gaming space

2.3

-

2.3

Relative Insight

AI-based text data analytics platform

-

0.8

0.8

Elucidat

An e-learning software authoring platform

-

0.3

0.3

Invested in the period

 

4.9

1.1

6.0

 

Subsequent to the period end, the Company has invested £0.8 million into portfolio company Force24.

Cash Deposits and other Liquid Funds

Given the current environment of rising interest rates the Company is taking an active approach to cash management, whilst pursuing its primary aim of capital preservation. This is effected through the use of a pool of money market funds (which can be converted back to cash with immediate notice), cash deposits with tier one banking institutions, and a small, diversified portfolio of listed investment funds. At 30 September 2023 this listed portfolio was valued at £3.6 million, or 1.8 per cent of net assets; this reduced in value by £0.3 million in the period, predominantly driven by a reduction in the valuation of its bond investments.

?Portfolio

The top 10 investments had a combined value of £84.1 million, 64.5 per cent of the total portfolio.

 

Name of company

Sector

First investment

Amount invested

Value at 30 Sept 2023

Recognised income/proceeds to date

Return to date

£000

£000

£000

£000

Matillion Limited

Data

Nov 16

2,666

25,233

7,071

32,304

Unbiased EC1 Limited

Tech-enabled Services

Dec 19

5,596

11,559

-

11,559

Outpost VFX Limited

New Media

Feb 21

4,500

8,936

38

8,974

Displayplan Holdings Limited

Business Services

Jan 12

1,300

8,611

3,168

11,779

Elucidat Ltd

Application Software

May 19

4,260

6,494

197

6,691

Wooshii Limited

New Media

May 19

4,644

6,006

581

6,587

Force24 Ltd

Application Software

Nov 20

3,150

4,792

-

4,792

ACC Aviation Group Limited

Business Services

Nov 14

2,068

4,405

5,280

9,685

Vypr Validation Technologies Limited

Tech-enabled Services

Jan 21

3,300

4,119

-

4,119

Quality Clouds Limited

Cloud & DevOps

May 22

3,916

3,942

-

3,942

SharpCloud Limited

Data

Oct 19

3,407

3,859

-

3,859

DrDoctor (via ICNH Ltd)

Application Software

Feb 23

3,565

3,565

-

3,565

Tonkotsu Limited

Retail & Brands

Jun 19

2,388

2,961

-

2,961

Workbuzz Analytics Limited

Application Software

Jun 23

2,577

2,945

-

2,945

AutomatePro Limited

Cloud & DevOps

Dec 22

2,225

2,875

-

2,875

Traveltek Group Holdings Limited

Application Software

Oct 16

1,716

2,797

901

3,698

GEEIQ (via Checkpoint GG Limited)

Data

Sep 23

2,358

2,358

-

2,358

Frescobol Carioca Ltd

Retail & Brands

Mar 19

1,800

2,143

-

2,143

Relative Insight Limited

Tech-enabled Services

Mar 22

3,804

2,092

-

2,092

Summize Limited

Application Software

Oct 22

1,800

2,070

-

2,070

Plandek Limited

Cloud & DevOps

Oct 22

2,070

2,070

-

2,070

KeTech Enterprises Limited

Tech-enabled Services

Nov 15

2,000

2,059

2,599

4,658

Vuealta Holdings Limited

Tech-enabled Services

Sep 21

3,045

2,013

4,601

6,614

E2E Engineering Limited

Business Services

Sep 17

900

1,942

243

2,185

Xapien (via Digital Insight Technologies Limited)

Application Software

Mar 23

1,740

1,846

-

1,846

Biorelate Limited

Application Software

Nov 22

1,560

1,562

-

1,562

Panintelligence (via Paninsight Limited)

Data

Nov 19

1,500

1,500

-

1,500

Sipsynergy (via Hosted Network Services Limited)

Cloud & DevOps

Jun 16

2,654

1,346

1

1,347

Macro Art Holdings Limited

Business Services

Jun 14

1,260

1,210

1,002

2,212

£1 million and below

11,153

2,983

6,819

9,802

Total portfolio

 

 

88,922

130,293

32,501

162,794

Full disposals to date

76,675

-

149,724

149,724

Total portfolio

 

165,597

130,293

182,225

312,518

 

? Our Portfolio at a Glance

The charts on page 13 of the interim report illustrate the broad range of the investment portfolio.

?Principal Risks and Uncertainties

In accordance with DTR 4.2.7, the Board confirms that the principal risks and uncertainties facing the Company have not materially changed from those identified in the Annual Report and Accounts for the year ended 31 March 2023. The Board acknowledges that there is regulatory risk and continues to manage the Company's affairs in such a manner as to comply with section 274 of the Income Tax Act 2007.

In summary, the principal risks are:

 

> VCT Qualifying Status;

> Economic;

> Investment and Strategic;

> Regulatory;

> Legislative;

> Reputational;

> Operational;

> Cyber Security and Information Technology;

> ESG; and

> Liquidity.

Full details of the principal risks can be found in the financial statements for the year ended 31 March 2023 on pages 31 to 33, a copy of which is available at www.bscfunds.com.

?Directors' Responsibilities Statement

The directors of British Smaller Companies VCT plc confirm that, to the best of their knowledge, the condensed set of financial statements in this interim report have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" as adopted by the UK, and give a true and fair view of the assets, liabilities, financial position and profit and loss of British Smaller Companies VCT plc, and that the interim management report includes a true and fair review of the information required by DTR 4.2.7R and DTR 4.2.8R.

The directors of British Smaller Companies VCT plc are listed in note 10 of these interim financial statements.

By order of the Board

 

Rupert Cook

Chairman

Unaudited Statement of Comprehensive Income

for the six months ended 30 September 2023

Notes

Unaudited 6 months ended

30 September 2023

Unaudited 6 months ended

30 September 2022

Revenue

£000

Capital

£000

Total

£000

Revenue

£000

Capital

£000

Total

£000

Gains on investments held at fair value

6

-

2,280

2,280

-

650

650

Profit on disposal of investments

6

-

96

96

-

2,849

2,849

-

2,376

2,376

-

3,499

3,499

Income

2

1,629

-

1,629

658

-

658

Total income

1,629

2,376

4,005

658

3,499

4,157

Administrative expenses:

 

 

 

Manager's fee

(367)

(1,100)

(1,467)

(351)

(1,052)

(1,403)

Other expenses

(359)

-

(359)

(329)

-

(329)

(726)

(1,100)

(1,826)

(680)

(1,052)

(1,732)

Profit (loss) before taxation

903

1,276

2,179

(22)

2,447

2,425

Taxation

3

-

-

-

-

-

-

Profit (loss) for the period

903

1,276

2,179

(22)

2,447

2,425

?Total comprehensive income (expense) for the period

903

1,276

2,179

(22)

2,447

2,425

 

 

 

Basic and diluted earnings (loss) per ordinary share

5

0.38p

0.53p

0.91p

(0.01p)

1.31p

1.30p

 

The Total column of this statement represents the Company's Unaudited Statement of Comprehensive Income, prepared in accordance with UK adopted international accounting standards. The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (issued in July 2022 - "SORP") published by the Association of Investment Companies.

?Unaudited Balance Sheet

as at 30 September 2023

 

Notes

Unaudited

30 September

2023

£000

Unaudited

30 September

2022

£000

Audited

31 March

2023

£000

ASSETS

 

 

 

 

 

Non-current assets at fair value through profit or loss

Investments

6

130,293

99,010

123,361

Listed investment funds

6

3,620

4,181

4,045

Financial assets at fair value through profit or loss

6

133,913

103,191

127,406

Accrued income and other assets

1,891

1,014

1,556

135,804

104,205

128,962

Current assets

 

Accrued income and other assets

825

6,386

161

Current asset investments

32,500

14,471

7,501

Cash and cash equivalents

29,635

33,217

20,766

62,960

54,074

28,428

LIABILITIES

 

Current liabilities

 

Trade and other payables

(200)

(146)

(358)

Net current assets

62,760

53,928

28,070

Net assets

198,564

158,133

157,032

 

Shareholders' equity

 

Share capital

26,452

20,612

20,969

Share premium account

41,586

62,861

1,700

Capital reserve

75,609

34,245

82,893

Investment holding gains and losses reserve

52,397

39,138

49,215

Revenue reserve

2,520

1,277

2,255

Total shareholders' equity

198,564

158,133

157,032

Net asset value per ordinary share

7

82.4p

85.0p

83.7p

 

Signed on behalf of the Board

Rupert Cook

Chairman

?Unaudited Statement of Changes in Equity

for the six months ended 30 September 2023

 

 

Share capital

Share premium account

Capital reserve

Investment holding gains and losses reserve

Revenue reserve

Total equity

 

£000

£000

£000

£000

£000

£000

At 31 March 2022

20,510

62,123

33,620

41,982

1,299

159,534

Revenue loss for the period

-

-

-

-

(22)

(22)

Expenses charged to capital

-

-

(1,052)

-

-

(1,052)

Investment holding gain on investments held at fair value

-

-

-

650

-

650

Realisation of investments in the period

-

-

2,849

-

-

2,849

Total comprehensive income (expense) for the period

-

-

1,797

650

(22)

2,425

Issue of shares - DRIS

102

760

-

-

-

862

Issue costs

-

(22)

-

-

-

(22)

Purchase of own shares

-

-

(941)

-

-

(941)

Dividends

-

-

(3,725)

-

-

(3,725)

Total transactions with owners

102

738

(4,666)

-

-

(3,826)

Realisation of prior year investment holding gains

-

-

3,494

(3,494)

-

-

At 30 September 2022

20,612

62,861

34,245

39,138

1,277

158,133

Revenue return for the period

-

-

-

-

1,105

1,105

Expenses charged to capital

-

-

(1,159)

-

-

(1,159)

Investment holding gain on investments held at fair value

-

-

-

7,502

-

7,502

Realisation of investments in the period

-

-

2,364

-

-

2,364

Total comprehensive income for the period

-

-

1,205

7,502

1,105

9,812

Issue of shares - DRIS

357

2,485

-

-

-

2,842

Issue costs

-

(40)

-

-

-

(40)

Share premium cancellation

-

(63,606)

63,606

-

-

-

Purchase of own shares

-

-

(1,556)

-

-

(1,556)

Dividends

-

-

(12,032)

-

(127)

(12,159)

Total transactions with owners

357

(61,161)

50,018

-

(127)

(10,913)

Realisation of prior year investment holding losses

-

-

(2,575)

2,575

-

-

At 31 March 2023

20,969

1,700

82,893

49,215

2,255

157,032

Revenue return for the period

-

-

-

-

903

903

Expenses charged to capital

-

-

(1,100)

-

-

(1,100)

Investment holding gain on investments held at fair value

-

-

-

2,280

-

2,280

Realisation of investments in the period

-

-

96

-

-

96

Total comprehensive (expense) income for the period

-

-

(1,004)

2,280

903

2,179

Issue of share capital

5,356

40,893

-

-

-

46,249

Issue of shares - DRIS

127

911

-

-

-

1,038

Issue costs

-

(1,918)

-

-

-

(1,918)

Purchase of own shares

-

-

(1,200)

-

-

(1,200)

Dividends

-

-

(4,178)

-

(638)

(4,816)

Total transactions with owners

5,483

39,886

(5,378)

-

(638)

39,353

Realisation of prior year investment holding losses

-

-

(902)

902

-

-

At 30 September 2023

26,452

41,586

75,609

52,397

2,520

198,564

 

Reserves available for distribution

Under the Companies Act 2006, the capital reserve and the revenue reserve are distributable reserves. The table below shows amounts that are available for distribution.

Capital reserve

Revenue reserve

Total

£000

£000

£000

Distributable reserves as above

75,609

2,520

78,129

Less: Income/proceeds not yet distributable

(399)

(1,952)

(2,351)

Less: Cancelled share premium not yet distributable

(40,769)

-

(40,769)

Reserves available for distribution*

34,441

568

35,009

 

*subject to filing these interim financial statements at Companies House.

The capital reserve and the revenue reserve are both distributable reserves. These reserves total £78,129,000, representing a decrease of £7,019,000 in the period since 31 March 2023. The directors also consider the level of the investment holding gains and losses reserve and the future requirements of the Company when determining the level of dividend payments.

Of the potentially distributable reserves of £78,129,000 shown above, £2,351,000 relates to income and proceeds not yet distributable and £40,769,000 relates to cancelled share premium which becomes distributable from the dates shown below.

?Total share premium cancelled is available for distribution from the following dates:

£000

1 April 2024

7,157

1 April 2025

32,128

1 April 2026

1,484

Cancelled share premium account not yet distributable

40,769

 

?Unaudited Statement of Cash Flows

for the six months ended 30 September 2023

 

Notes

Unaudited

6 months

ended

30 September

2023

 

Unaudited

6 months

ended

30 September

 2022

 

Audited

year

ended

31 March

 2023

 

£000

£000

£000

Profit before taxation

2,179

2,425

12,237

Decrease in trade and other payables

(158)

(641)

(429)

Increase in accrued income and other assets

(599)

(224)

(660)

Profit on disposal of investments

(96)

(2,849)

(5,213)

Gains on investments held at fair value

(2,280)

(650)

(8,152)

Capitalised income

-

-

(60)

Net cash outflow from operating activities

(954)

(1,939)

(2,277)

 

Cash flows from (used in) investing activities

 

Cash maturing from fixed term deposits

-

-

6,970

Purchase of financial assets at fair value through profit or loss

6

(6,039)

(8,778)

(28,832)

Proceeds from sale of financial assets at fair value through profit or loss

6

1,508

8,832

20,716

Net cash (outflow) inflow from investing activities

(4,531)

54

(1,146)

 

Cash flows from (used in) financing activities

 

Issue of ordinary shares

46,249

-

-

Costs of ordinary share issues*

(1,918)

(22)

(62)

Purchase of own shares

(1,200)

(941)

(2,497)

Dividends paid

4

(3,778)

(2,863)

(12,180)

Net cash inflow (outflow) from financing activities

39,353

(3,826)

(14,739)

 

Net increase (decrease) in cash and cash equivalents

33,868

(5,711)

(18,162)

Cash and cash equivalents at the beginning of the period

28,267

46,429

46,429

Cash and cash equivalents at the end of the period

62,135

40,718

28,267

 

Cash and cash equivalents comprise

 

Money market funds

32,500

7,501

7,501

Cash at bank

29,635

33,217

20,766

Cash and cash equivalents at the end of the period

62,135

40,718

28,267

 

*Issue costs include both fundraising costs and expenses incurred from the Company's DRIS.

 

Explanatory Notes to the Unaudited Condensed Financial Statements

1 General Information, Basis of Preparation and Principal Accounting Policies

These half year statements have been approved by the directors whose names appear at note 10, each of whom has confirmed that to the best of their knowledge:

> the interim management report includes a fair review of the information required by rules 4.2.7 and 4.2.8 of the Disclosure Rules and the Transparency Rules; and

> the half year statements have been prepared in accordance with IAS 34 'Interim financial reporting' and the Disclosure and Transparency Rules of the Financial Conduct Authority.

The half year statements are unaudited and have not been reviewed by the auditors pursuant to the International Standard on Review Engagements (UK) 2410 guidance on Review of Interim Financial Information performed by the independent Auditor of the entity. They do not constitute full financial statements as defined in section 435 of the Companies Act 2006. The comparative figures for the year ended 31 March 2023 do not constitute full financial statements and have been extracted from the Company's financial statements for the year ended 31 March 2023. Those accounts were reported upon without qualification by the auditors and have been delivered to the Registrar of Companies.

The accounting policies and methods of computation followed in the half year statements are the same as those adopted in the preparation of the audited financial statements for the year ended 31 March 2023. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the 2023 annual report.

The accounts have been prepared on a going concern basis as set out below and in accordance with UK adopted international accounting standards.

The accounts have been prepared under the historical cost basis as modified by the measurement of investments at fair value through profit or loss.

The accounts have been prepared in compliance with the recommendations set out in the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the Association of Investment Companies (issued in July 2022 - "SORP") to the extent that they do not conflict with UK adopted international accounting standards.

The financial statements are prepared in accordance with UK adopted international accounting standards (IFRSs) and interpretations in force at the reporting date. New standards coming into force during the period and future standards that come into effect after the period-end have not had a material impact on these financial statements.

The Company has carried out an assessment of accounting standards, amendments and interpretations that have been issued by the IASB and that are effective for the current reporting period. The Company has determined that the transitional effects of the standards do not have a material impact.

The financial statements are presented in sterling and all values are rounded to the nearest thousand (£000), except where stated.

Going Concern: The directors have carefully considered the issue of going concern and are satisfied that the Company has sufficient resources to meet its obligations as they fall due for a period of at least 12 months from the date these half year statements were approved. As at 30 September 2023 the Company held cash balances, fixed term deposits and other liquid resources with a combined value of £65,755,000. Cash flow projections show the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of share buy-backs and the dividend policy for at least 12 months from the date of publication of this report.

In the year ended 31 March 2023 the Company's costs and discretionary expenditures were:

£000

Administrative expenses (before fair value movements related to credit risk and incentive fee)

3,480

Share buy-backs

2,497

Dividends (before DRIS)

15,884

Total

21,861

 

The directors therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing these half year statements.

2 Income

Unaudited

6 months

ended 30

September

2023

£000

Unaudited

6 months

ended 30

September

2022

£000

Income from investments

- Interest on loans to unquoted companies

103

297

- Dividends from unquoted companies

243

172

Income from unquoted portfolio

346

469

Income from listed investment funds

62

54

Income from investments held at fair value through profit or loss

408

523

Interest on bank deposits/money market funds

1,221

135

1,629

658

 

3 Taxation

 

Unaudited 6 months ended

30 September 2023

Unaudited 6 months ended

30 September 2022

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

Profit (loss) before taxation

903

1,276

2,179

(22)

2,447

2,425

Profit (loss) before taxation multiplied by the standard small company rate of corporation tax in UK of 19.0% (2022: 19.0%)

172

242

414

(4)

465

461

Effect of:

 

 

 

UK dividends received

(47)

-

(47)

(35)

-

(35)

Non-taxable profits on investments

-

(451)

(451)

-

(665)

(665)

Deferred tax not recognised

(125)

209

84

39

200

239

Tax charge

-

-

-

-

-

-

 

The Company has no provided, or unprovided, deferred tax liability in either period.

Deferred tax assets in respect of losses have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which the assets can be recovered.

Due to the Company's status as a venture capital trust, and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, the Company has not provided deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.

4 Dividends

Amounts recognised as distributions to equity holders in the period:

 

Unaudited 6 months ended

30 September 2023

Unaudited 6 months ended

30 September 2022

Revenue

Capital

Total

Revenue

Capital

Total

£000

£000

£000

£000

£000

£000

First interim dividend for the year ending 31 March 2024 of 2.0p (2023: 2.0p) per ordinary share

638

4,178

4,816

-

3,725

3,725

Proceeds from shares allotted under DRIS

 

 

(1,038)

(862)

Dividends paid in the Statement of Cash Flows

 

 

3,778

2,863

 

Audited year ended

31 March 2023

Revenue

Capital

Total

£000

£000

£000

First interim dividend for the year ending 31 March 2023 of 2.0p per ordinary share

-

3,725

3,725

Second interim dividend for the year ended 31 March 2023 of 5.0p per ordinary share

-

3,736

3,736

Third interim dividend for the year ended 31 March 2023 of 2.0p per ordinary share

127

8,296

8,423

127

15,757

15,884

Proceeds from shares allotted under DRIS

(3,704)

Dividends paid in the Statement of Cash Flows

12,180

 

The interim dividend of 2.0 pence per ordinary share was paid on 28 July 2023 to shareholders on the register as at 30 June 2023.

A second interim dividend of 2.0p per ordinary share, amounting to approximately £4.8 million, has been announced. This dividend has not been recognised in these half year financial statements as the obligation did not exist at the balance sheet date.

5 Basic and Diluted Earnings per Ordinary Share

The basic and diluted earnings per ordinary share is based on the profit after tax attributable to equity shareholders of £2,179,000 (30 September 2022: £2,425,000) and 240,246,488 (30 September 2022: 186,454,862) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted revenue earnings (loss) per ordinary share is based on the revenue profit attributable to equity shareholders of £903,000 (30 September 2022: loss of £22,000) and 240,246,488 (30 September 2022: 186,454,862) ordinary shares being the weighted average number of ordinary shares in issue during the period.

The basic and diluted capital earnings per ordinary share is based on the capital profit attributable to equity shareholders of £1,276,000 (30 September 2022: £2,447,000) and 240,246,488 (30 September 2022: 186,454,862) ordinary shares being the weighted average number of ordinary shares in issue during the period.

During the period the Company allotted 53,559,905 new ordinary shares in respect of the 2022/23 fundraising and 1,270,231 new ordinary shares in respect of its DRIS.

The Company has also repurchased 1,517,931 of its own shares in the period and these shares are held in the capital reserve. The total of 23,525,696 treasury shares has been excluded in calculating the weighted average number of ordinary shares during the period.

The Company has no dilutive shares and consequently, basic and diluted earnings per ordinary share are equivalent at 30 September 2023, 31 March 2023 and 30 September 2022.

6 Financial Assets at Fair Value through Profit or Loss

IFRS 13 and IFRS 7, in respect of financial instruments that are measured in the balance sheet at fair value, require disclosure of fair value measurements by level within the following fair value measurement hierarchy:

> Level 1: quoted prices in active markets for identical assets or liabilities. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is defined as a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. The quoted market price used for financial assets held by the Company is the current bid price. These instruments are included in Level 1 and comprise listed investment funds classified as held at fair value through profit or loss.

> Level 2: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable market data where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in Level 2. The Company held no such instruments in the current or prior year.

> Level 3: the fair value of financial instruments that are not traded in an active market (for example, investments in unquoted companies) is determined by using valuation techniques such as earnings or revenue multiples. If one or more of the significant inputs is not based on observable market data, the instrument is included in Level 3. The majority of the Company's investments fall into this category.

Each investment is reviewed at least quarterly to ensure that it has not ceased to meet the criteria of the level in which it was included at the beginning of each accounting period. There have been no transfers between these classifications in the period (2022: none).

The change in fair value for the current and previous year is recognised through profit or loss. All items held at fair value through profit or loss were designated as such upon initial recognition.

Valuation of Investments

Unquoted investments are valued in accordance with IFRS 13 "Fair Value Measurement" and using the International Private Equity and Venture Capital ("IPEVC") Valuation Guidelines ("the Guidelines") issued in December 2022.

Initial measurement

The best estimate of the initial fair value of an unquoted investment is the cost of the investment. Unless there are indications that this is inappropriate, an unquoted investment will be held at this value within the first three months of investment.

Subsequent measurement

Based on the Guidelines we have identified six of the most widely used valuation methodologies for unquoted investments. The Guidelines advocate that the best valuation methodologies are those that draw on external, objective market-based data in order to derive a fair value.

Full details of the methods used by the Company were set out on pages 66 and 67 of the financial statements for the year ended 31 March 2023, a copy of which can be found at www.bscfunds.com.

The primary methods used for valuing non-quoted investments, and the key assumptions relating to them are:

Unquoted Investments

> revenue multiple. An appropriate multiple, given the risk profile and revenue growth prospects of the underlying company, is applied to the revenue of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

> earnings multiple. An appropriate multiple, given the risk profile and earnings growth prospects of the underlying company, is applied to the maintainable earnings of the company. The multiple is adjusted to reflect any risk associated with lack of marketability and to take account of the differences between the investee company and the benchmark company or companies used to derive the multiple.

Movements in investments at fair value through profit or loss during the six months to 30 September 2023 are summarised as follows:

 

IFRS 13 measurement classification

Level 3

Level 1

Total

Unquoted investments

Listed investment funds

investments

£000

£000

£000

Opening cost

73,515

4,676

78,191

Opening valuation gain (loss)

49,846

(631)

49,215

Opening fair value at 1 April 2023

123,361

4,045

127,406

Additions at cost

6,039

-

6,039

Disposal proceeds

(1,668)

(147)

(1,815)

Net profit (loss) on disposals*

9

(6)

3

Change in fair value

2,228

(272)

1,956

Foreign exchange gain

324

-

324

Closing fair value at 30 September 2023

130,293

3,620

133,913

Closing cost

77,041

4,475

81,516

Closing valuation gain (loss)

53,252

(855)

52,397

Closing fair value at 30 September 2023

130,293

3,620

133,913

 

* The net profit on disposals in the table above is £3,000 whereas that shown in the Statement of Comprehensive Income is £96,000. The difference comprises deferred proceeds in respect of assets which have been disposed of in prior periods and were not included in the portfolio at 1 April 2023.

Level 3 valuations include assumptions based on non-observable data, such as discounts applied either to reflect changes in the fair value of financial assets held at the price of recent investment, or to adjust revenue or earnings multiples.

IFRS13 requires disclosure, by class of financial instruments, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to fair value measurement. Each unquoted portfolio company has been reviewed and both downside and upside alternative assumptions have been identified and applied to the valuation of each of the unquoted investments. Applying the downside alternative, the value of the unquoted investments would be £6,220,000 (4.8 per cent) lower. Using the upside alternative, the value would be increased by £6,157,000 (4.7 per cent).

97 per cent of the Company's investments are in unquoted companies held at fair value. The valuation methodology for these investments includes the application of externally produced revenue and earnings multiples. Therefore, the value of the unquoted element of the portfolio is also indirectly affected by price movements on the listed market. Those using revenue and earnings multiple methodologies include judgements regarding the level of discount applied to that multiple. The effect of changing the level of discounts applied to the multiples is considered above.

3 per cent of the Company's investments are investment funds listed on the main market of the London Stock Exchange (including FCA authorised and regulated UCITS funds). A 5 per cent increase in stock prices as at 30 September 2023 would have increased the net assets attributable to the Company's shareholders and the total profit by £181,000. An equal change in the opposite direction would have decreased the net assets attributable to the Company's shareholders and the total profit by an equal amount.

There have been no individual fair value adjustments downwards during the period that exceeded 5 per cent of the total assets of the Company (31 March 2023: none).

The following disposals took place during the period.

 

Net proceeds from sale

Cost

Opening carrying value as at 1 April 2023

Profit (loss) over opening carrying value

 

£000

£000

£000

£000

Unquoted investments

 

 

 

 

Ncam Technologies Limited

1,668

2,512

1,659

9

Total from portfolio

1,668

2,512

1,659

9

Listed investment funds

147

202

153

(6)

Total from investment portfolio

1,815

2,714

1,812

3

Deferred consideration - Wakefield Acoustics (via Malvar Engineering Limited)

93

-

-

93

Total from investment portfolio

1,908

2,714

1,812

96

 

The total from disposals in the table above is £1,908,000 whereas that shown in the Statement of Cash Flows is £1,508,000. This is due to the timing differences between the recognition of the deferred income and its receipt in cash.

7 Basic and Diluted Net Asset Value per Ordinary Share

The basic and diluted net asset value per ordinary share is calculated on attributable assets of £198,564,000 (30 September 2022 and 31 March 2023: £158,133,000 and £157,032,000 respectively) and 240,991,484 (30 September 2022 and 31 March 2023: 186,112,757 and 187,679,279 respectively) ordinary shares in issue at 30 September 2023.

The treasury shares have been excluded in calculating the number of ordinary shares in issue at 30 September 2023.

The Company has no potentially dilutive shares and consequently, basic and diluted net asset values are equivalent at 30 September 2023, 31 March 2023 and 30 September 2022.

8 Total Return

Total Return per ordinary share is calculated on cumulative dividends paid of 176.9 pence per ordinary share (30 September 2022: 168.4 pence per ordinary share and 31 March 2023: 174.9 pence per ordinary share) plus the net asset value as calculated in note 7.

9 Post Balance Sheet Events

Subsequent to the period end the Company has invested £0.8 million into portfolio company Force24.

In November 2023, the Company exited its investments in E2E for £2.0 million and MacroArt for £1.5 million, in line with the companies' valuations at 30 September 2023.

10 Directors

The directors of the Company are: Rupert Cook, Adam Bastin, Jonathan Cartwright and Purvi Sapre.

11 Interim Dividend for the year ending 31 March 2024

The directors have previously announced the payment of a second interim dividend for the year ending 31 March 2024 of 2.0 pence per ordinary share ("Interim Dividend").

The Interim Dividend will be paid on 8 December 2023 to those shareholders on the Company's register at the close of business on 10 November 2023. The ex-dividend date will be 9 November 2023.

12 Dividend Re-investment Scheme ("DRIS")

The Company operates a DRIS. The latest date for receipt of DRIS elections so as to participate in the DRIS in respect of the Interim Dividend is the close of business on 24 November 2023.

13 Inside Information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BIBDBSDDDGXX
Date   Source Headline
3rd Apr 20247:58 amRNSIssue of Equity and Close of Offers
26th Mar 202411:11 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNS3rd Quarter Results
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:23 amRNSIssue of Equity
18th Dec 20234:02 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
8th Dec 20239:47 amRNSPayment of Dividend and Issue of Equity
24th Nov 20237:00 amRNSHalf-year Report
26th Oct 20231:34 pmRNSDividend Declaration
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:20 amRNSTransaction in Own Shares and PDMR
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
14th Sep 202310:28 amRNSResult of AGM
14th Sep 202310:28 amRNSResult of General Meeting
13th Sep 20237:00 amRNS1st Quarter Results
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
28th Jul 202310:00 amRNSDirector/PDMR Shareholding
28th Jul 202310:00 amRNSPayment of Dividend and Issue of Equity
27th Jun 20237:45 amRNSTransaction in Own Shares
21st Jun 20231:00 pmRNSPublication of Circular
16th Jun 202312:00 pmRNSAnnual Financial Report
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:23 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:42 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNS3rd Quarter Results
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSDirector/PDMR Shareholding
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:48 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.